BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23400686)

  • 1. Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.
    Dionysopoulos D; Pavlakis K; Kotoula V; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Nikolaou A; Kalogeras KT; Fountzilas G
    Strahlenther Onkol; 2013 Mar; 189(3):202-14. PubMed ID: 23400686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
    Mountzios G; Kostopoulos I; Kotoula V; Sfakianaki I; Fountzilas E; Markou K; Karasmanis I; Leva S; Angouridakis N; Vlachtsis K; Nikolaou A; Konstantinidis I; Fountzilas G
    PLoS One; 2013; 8(1):e54048. PubMed ID: 23365645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
    Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.
    Bellacosa A; Almadori G; Cavallo S; Cadoni G; Galli J; Ferrandina G; Scambia G; Neri G
    Clin Cancer Res; 1996 Jan; 2(1):175-80. PubMed ID: 9816104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis.
    Chrysovergis A; Gorgoulis VG; Giotakis I; Tsiambas E; Karameris A; Kittas C; Kyroudi A
    Med Oncol; 2011 Sep; 28(3):871-7. PubMed ID: 20373052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Ahmed RA; Shawky Ael-A; Hamed RH
    Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR; Wu HG; Park CI; Jun YK; Kim CW
    Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 protein tissue detection in laryngeal cancer.
    Segas JV; Lazaris AC; Nikolopoulos TP; Kavantzas NG; Lendari IE; Tzagkaroulakis AM; Patsouris ES; Ferekidis EA
    ORL J Otorhinolaryngol Relat Spec; 2005; 67(6):319-25. PubMed ID: 16327270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.
    Lazaridis G; Lambaki S; Karayannopoulou G; Eleftheraki AG; Papaspirou I; Bobos M; Efstratiou I; Pentheroudakis G; Zamboglou N; Fountzilas G
    Strahlenther Onkol; 2014 Jul; 190(7):636-8, 640-5. PubMed ID: 24658605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
    Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
    J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
    Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
    Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
    Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
    Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.
    Pignataro L; Sambataro G; Pagani D; Pruneri G
    Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):75-85. PubMed ID: 16116829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
    Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
    Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.